Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyoti Mayadev

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Oncology|February 23, 2017
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional StudyKevin Albuquerque, Michael Folkert, Jyoti Mayadev, et al.
The Lancet. Oncology|October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
Magnetic Resonance Imaging|April 18, 2026
Development and evaluation of a cervical cancer-specific restriction spectrum imaging (RSI) modelAna E Rodríguez-Soto, Christopher Conlin, Jingjing Zuo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 29, 2021
Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT RadiomicsTahir I Yusufaly, Jingjing Zou, Tyler J Nelson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2021
Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III TrialCasey W Williamson, Igor Sirák, Ronghui Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate ImmunotherapyJacqueline Lesperance, Bryan S Yung, Michael M Allevato, et al.
Brachytherapy|October 17, 2025
Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancerHayeon Kim, Wei Deng, Dimitriy Zamarin, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Nature Communications|January 9, 2025
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trialJyoti Mayadev, Dmitriy Zamarin, Wei Deng, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|February 23, 2017
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional StudyKevin Albuquerque, Michael Folkert, Jyoti Mayadev, et al.
The Lancet. Oncology|October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
Magnetic Resonance Imaging|April 18, 2026
Development and evaluation of a cervical cancer-specific restriction spectrum imaging (RSI) modelAna E Rodríguez-Soto, Christopher Conlin, Jingjing Zuo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 29, 2021
Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT RadiomicsTahir I Yusufaly, Jingjing Zou, Tyler J Nelson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2021
Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III TrialCasey W Williamson, Igor Sirák, Ronghui Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 24, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate ImmunotherapyJacqueline Lesperance, Bryan S Yung, Michael M Allevato, et al.
Brachytherapy|October 17, 2025
Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancerHayeon Kim, Wei Deng, Dimitriy Zamarin, et al.
BJU International|January 14, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPeter Grimm, Ignace Billiet, David Bostwick, et al.
Nature Communications|January 9, 2025
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trialJyoti Mayadev, Dmitriy Zamarin, Wei Deng, et al.
Pageof 8